Be clear on what you have and how much.
Understand ADC drug loading profiles regardless of the inherent heterogeneity and high molecular weight of these molecules.
Be clear on what you have and how much.
Understand ADC drug loading profiles regardless of the inherent heterogeneity and high molecular weight of these molecules.
Explore the latest and trending topics
Webinar
Enable mass identification of charge variants and modifications on intact ADCs
Reduce charge heterogeneity analysis from weeks to minutes. Identify and monitor the charged modification on ADC payloads in near real-time.
Hub
Deep dive into the characterization of an antibody drug conjugate
Up your game for ADC analysis with innovative analytical strategies presented by leaders in the field.
Vodcast
Rewrite the Rules
Hear insights from leading scientists on how they have moved past conventional norms to overcome significant analytical challenges in the biopharmaceutical space.
Up the game for ADC analysis
ADC analysis strategies tackle the characterization of the more structurally complex antibody drug conjugates (ADC) that are providing the next level of therapeutics to combat specific conditions.
These molecules have greater heterogeneity compared to unconjugated proteins and have a variable number of linkers and payloads. This enhances the number of proteoforms, making characterization more challenging.
Take control of the information with MS and CE based solutions designed to address the complexity of these next generation therapeutics with increased speed and detail.
Untangle the charge heterogeneity information of an intact ADC.
Charge heterogeneity is present in most biopharmaceutical protein products. For ADCs, the antibody, linker and payload all contribute to the heterogeneity, adding complexity to the charge variant profiles.
An integrated icIEF-UV/MS workflow enables the simple determination of charge variant profiles while reducing resources and accelerating development timelines. Determine what is driving the change in the charge profile–the payload, the linker or the monoclonal antibody (mAb).
Suited for:
Eliminate the guess work and monitor biologics at the intact-protein level, gaining insights into charge variant-associated quality attributes.
Be empowered with highly accurate and informative workflows for fully characterizing protein therapeutics and viral vector proteins.
Workflow
Take control of information on ADC quality. Drug antibody ratio (DAR) information is essential for assessing the quality of ADCs. Be clear on what you have. Understand ADC drug loading profiles with high throughput and intuitive LC/MS and CE solutions for DAR monitoring at the intact protein level.
Technical note
Enable faster decision making with high-throughput and intuitive DAR monitoring for ADCs
Streamlined LC-MS based workflows, with user-friendly data analysis software to enable attribute monitoring and informed decision making during process development.
Technical note
Automate DAR calculation at the intact level
Ensure product quality and make ADC analysis accessible with a visually intuitive workflow for routine ADC characterization.
Suited for:
Reproducibility, reliability and carryover performance to match your quantitative workflows. Dependability you can count on, from injection to injection and batch after batch.
A high-resolution mass spectrometry solution that combines powerful MS/MS sensitivity, fragmentation technology and a step-change in data independent acquisition.
Be empowered with highly accurate and informative workflows for fully characterizing protein therapeutics and viral vector proteins.
Suited for:
Reproducibility, reliability and carryover performance to match your quantitative workflows. Dependability you can count on, from injection to injection and batch after batch.
A purpose-built QTOF system, designed specifically to accelerate everyday biologics characterization.
Unleash the analytical power of the next-generation software platform for data acquisition and processing.
Characterize therapeutic molecules with confidence with the kit-based system.
Effective quantification and determination of protein purity and size.
Workflow
Build on a strong backbone.
ADCs are complex molecules consisting of an antibody chemically tethered to a drug payload. While the complexity of the association is important to understand, the raw material itself is also fundamental to the success of the method of action and requires characterization. Accelerate ADC analysis with characterization of raw materials using high-throughput CE-based workflows.
Technical note
Eliminate the bottleneck for drug purity analysis with high-throughput rapid CE-SDS purity analysis
Screen a large number of clones for lead clone selection with automation friendly mulit-capillary CE-SDS workflow.
Technical note
Accelerate cIEF method development from days to hours
Streamline evaluation of multiple factors in a single set of experiments with a multifactorial DoE approach.
Technical note
Enable a streamlined, accurate and high-throughput glycan analysis assay
High throughput glycan expression profiling with automation friendly sample preparation and labeling.
Suited for:
Purpose-built for the biopharmaceutical scientist for efficiency and quality, enabling multiple samples to be run in parallel.
Effective quantification and determination of protein purity and size.
Suited for:
Purpose-built for the biopharmaceutical scientist for efficiency and quality, enabling multiple samples to be run in parallel.
Experimental protein isoelectric focusing point (pI) and analysis of charge variants.
Suited for:
Purpose-built for the biopharmaceutical scientist for efficiency and quality, enabling multiple samples to be run in parallel.
Release and label glycoprotein N-linked glycans for high-resolution capillary electrophoresis using laser-induced fluorescence (LIF) detection and an HR-NCHO separation matrix.
Technical note
Automate DAR calculation at the intact level
Ensure product quality and make ADC analysis accessible with a visually intuitive workflow for routine ADC characterization.
Technical note
Enable comprehensive analysis of mAbs and ADCs in a single injection
Gain accurate localization and detailed structural characterization with improved sensitivity for confident detection of fragments.
Webinar
Enable mass identification of charge variants and modifications on intact ADCs
Reduce charge heterogeneity analysis from weeks to minutes. Identify and monitor the charged modifications on ADC payloads in near real-time.
Webinar
Comprehensive characterization of protein therapeutics
Gain high sequence coverage for proteins and identify critical modifications on a single platform solution.
Technical note
Enable faster decision making with high-throughput and intuitive DAR monitoring for ADCs
Streamlined LC-MS based workflows, with user-friendly data analysis software to enable attribute monitoring and informed decision making during process development.
Technical note
Eliminate the bottleneck for drug purity analysis with high-throughput rapid CE-SDS purity analysis
Screen a large number of clones for lead clone selection with automation friendly mulit-capillary CE-SDS workflow.
Technical note
Accelerate cIEF method development from days to hour
Streamline evalutaion of multiple factors in a single set of experiments with a multifactorial DoE approach.
Technical note
Enable a streamlined, accurate and high-throughput glycan analysis assay
High throughput glycan expression profiling with automation friendly sample preparation and labeling.
Confidently select lead candidates and ensure reproducible product quality. Discover fast and reliable solutions that simplify identification and characterization of complex molecules at the intact level.
Take control of the unknowns. Gain confident sequence confirmation and localization of post-translational modifications (PTMs) at the sub-unit level.
Achieve new heights in PTM analysis with confidence and speed. Define critical quality attributes (CQAs) and streamline processes from early to late-stage development with in-depth peptide mapping solutions for next-generation protein therapeutics and standard monoclonal antibodies (mAbs).